Dec 1 (Reuters) - Biotelemetry Inc -
* Announces acquisition of Telcare’s remote diabetes management platform
* Acquired Telcare Medical Supply, Inc. and associated assets for upfront consideration of $7.0 million in cash
* Telcare is expected to generate over $5.0 million in revenue on an annualized basis and be near breakeven by end of 2017
* Deal includes potential for additional performance-based earn-outs of up to $5.0 million in cash Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.